Mark Springer is currently the Director of Global Trial Optimization at Regeneron Pharmaceuticals, Inc., a position they have held since 2023. They previously served as Associate Director of Global Trial Optimization at Regeneron from 2019 to 2022 and held various roles at Eli Lilly and Company, including Consultant in Clinical Innovation. Their career began as a Field Sales Representative at Bristol-Myers Squibb in 1997. Mark holds a Bachelor's Degree in Health Care Administration from Indiana University Bloomington, which they earned in 1996.
This person is not in the org chart
This person is not in any teams
This person is not in any offices